Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-10
2005-05-10
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S380000, C530S381000, C530S382000
Reexamination Certificate
active
06890903
ABSTRACT:
Use of factor XIII for inhibiting the formation of seromas by administering factor XIII. The factor XIII can be administered locally at the site of a wound or surgery or administered systemically. If the factor XIII is administered locally, it can be activated or non-activated and may be administered in conjunction with activated thrombin.
REFERENCES:
patent: 5378687 (1995-01-01), Urabe et al.
patent: 6197325 (2001-03-01), MacPhee et al.
patent: 6656496 (2003-12-01), Kilpadi et al.
patent: 0268772 (1995-04-01), None
patent: 0236978 (1995-06-01), None
patent: 0691850 (2002-09-01), None
Research Report.
D'Argenio et al.,Dig Dis Sci45(5):987-997, 2000.
Nielsen et al.,Cytokines Cell Mol Ther3:267-281, 1997.
Bishop et al.,Biochemistry29(7):1861-1869, 1990.
Herouy et al.,Lancet355:1970-1971, 2000.
Peschen et al.,Vasa27(2):89-93, 1998.
Wozniak et al.,Sem Thromb Hemost22(5);445-450, 1996.
Mishima et al.,Chirurg55:803-808, 1984.
Board et al.,Blood Rev7(4):229-242, 1993.
Bregenzer et al.,Z Gastroenterol37(10):999-1004, 1999.
Lorenz et al.,Sem Throm Hemost22(5):451-455,.1996.
Oshitani et al.,Lancet347:119-120, 1996.
Suzuki et al.,Blut59(2):162-164, 1989.
Von Bierbrauer et al.,Infusionstherapie und Transfusionmedizin24:348-353, 1997.
Utani et al.,J Am Acad Dermatol24(3):438-442, 1991.
Kamitsuji et al.,Eur J Pediatr146(5):519-523, 1987.
Ichinose et al.,Biochemistry25(22):6900-6906, 1986.
Becker et al.,Spinal Cord39(2):114-117, 2001.
Isogai et al.,Microsurgery11:40-46, 1990.
Weiss et al.,J Cell Physiol174:58-65, 1998.
Cario et al.,Scand J Gastoenterol485-490, 1999.
Vanscheidt et al.,Acta Derm Venereol(Stockh) 71:55-57, 1991.
Bishop Paul D.
Grossmann Angelika
Wax Robert A.
Zymogenetics Inc.
LandOfFree
Method for inhibiting the formation of seromas using factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting the formation of seromas using factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting the formation of seromas using factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3370778